This observation sheds light on the crucial oncogenic function of the RBM33/ALKBH5 signaling pathway in HNSCC, as demonstrated by various mouse tumor models, including a xenograft model utilizing patient-derived tumors. This evidence concerns the gene ALKBH5 and head and neck squamous cell carcinoma.